Following a court judgment in its favor last year, Merck & Co. is formally bidding adieu to more than 1,000 lawsuits alleging its shingles vaccine Zostavax caused patients to develop the disease.

With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

The Merck vaccine is a regimen designed to prevent the onset of shingles, which is caused by the reemergence of dormant chicken pox virus.The U.S. Food and Drug Administration (FDA) has extended the ...

The order mandated all remaining plaintiffs to produce similar clinical evidence to support their claims. Merck countered that the cases lacked merit without conclusive evidence linking the vaccine to ...

Oct 18 (Reuters) - The federal trial judge overseeing a four-year-old multidistrict litigation over Merck’s Zostavax shingles vaccine decided in March 2022 that it was time for plaintiffs to put up or ...

Merck (MRK) is cautiously optimistic that Zostavax, a shingles vaccine, will finally live up to its potential, says the Wall Street Journal. Justin Boone breaks down which players have the easiest ...

WASHINGTON (Reuters) - U.S. health officials on Thursday recommended that people 60 and older get Merck & Co Inc's vaccine Zostavax to protect against shingles, a viral infection that causes a painful ...

ATLANTA — An influential government advisory panel has recommended that Americans 60 and older get vaccinated against shingles, an excruciatingly painful rash caused by the same virus that causes ...

NEW YORK, Oct 21 (Reuters) - In a huge study aimed at broadening the use of Merck & Co's shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo ...

Merck & Co. customers have had to wait months for shingles vaccine shipments through much of this year, but the drugmaker says production should catch up with demand early next year. At Kohll's ...